Next-generation diagnostics with eye-tracking
Our Clinical Importance
Here you can download our new HUB brochure
Our aim is to offer clinicians and researchers one device that can perform multiple rapid neuro-ophthalmic eye examination tests. Our unique BulbiHUB platform and BulbiCAM currently offers the user multiple tests to screen for glaucoma, age-related macular degeneration (AMD) , nystagmus, cataract and optic neuritis. Ultimately our BulbiCAM will include multiple tests to screen for both ophthalmological and neurological conditions.
Our technology maintains good vision and cognitive health across a lifetime.
BulbiCAM - Multiple rapid eye examination tests to screen for ophthalmological and neurological conditions
Benefits of Our Technology
Problems We Solve
Diagnostic tool in mastering a complete neuro-ophthalmic assessment of the patient
Funding from public funds and private investors for technology development
Technical R&D development on platform & hardware
Company & software CE-certified
Funding from public funds and private investors to complete smaller prototype.
Certified acc to ISO 13485:2016
Finalist in the DNB Healthcare prize
Bulbitech wins healthcare pitching contest at Oslo Innovation Week
Bulbitech is FDA registered under number D437315
Awarded € 2 million euro grant from Norwegian Research Council for clinical validation of tests
Semifinalist EIT Health Catapult 2022-2023.
Certified acc to 27001:2013
Completed two validation studies in neurology (Parkinson’s & Ataxia)